CN106138199A - 一种提供眼睛营养保护视力的复合配方及其制备方法 - Google Patents
一种提供眼睛营养保护视力的复合配方及其制备方法 Download PDFInfo
- Publication number
- CN106138199A CN106138199A CN201610624311.4A CN201610624311A CN106138199A CN 106138199 A CN106138199 A CN 106138199A CN 201610624311 A CN201610624311 A CN 201610624311A CN 106138199 A CN106138199 A CN 106138199A
- Authority
- CN
- China
- Prior art keywords
- powder
- microcapsule powder
- eyes
- compound prescription
- microcapsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004438 eyesight Effects 0.000 title claims abstract description 17
- 150000001875 compounds Chemical class 0.000 title claims abstract description 16
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 14
- 230000035764 nutrition Effects 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims description 8
- 239000000843 powder Substances 0.000 claims abstract description 41
- 239000003094 microcapsule Substances 0.000 claims abstract description 29
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 16
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 14
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 claims abstract description 12
- 239000004212 Cryptoxanthin Substances 0.000 claims abstract description 12
- 235000002360 beta-cryptoxanthin Nutrition 0.000 claims abstract description 12
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 claims abstract description 12
- 235000019244 cryptoxanthin Nutrition 0.000 claims abstract description 12
- 229940055416 blueberry extract Drugs 0.000 claims abstract description 10
- 235000019216 blueberry extract Nutrition 0.000 claims abstract description 10
- 235000013305 food Nutrition 0.000 claims abstract description 10
- 239000004376 Sucralose Substances 0.000 claims abstract description 9
- 235000013336 milk Nutrition 0.000 claims abstract description 9
- 239000008267 milk Substances 0.000 claims abstract description 9
- 210000004080 milk Anatomy 0.000 claims abstract description 9
- 235000019408 sucralose Nutrition 0.000 claims abstract description 9
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims abstract description 9
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 9
- 239000008158 vegetable oil Substances 0.000 claims abstract description 9
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 8
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 7
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 7
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 7
- 235000012239 silicon dioxide Nutrition 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 22
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000003562 lightweight material Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims 1
- 238000001179 sorption measurement Methods 0.000 abstract description 3
- 210000001525 retina Anatomy 0.000 description 5
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 4
- 102000004330 Rhodopsin Human genes 0.000 description 4
- 108090000820 Rhodopsin Proteins 0.000 description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 240000000851 Vaccinium corymbosum Species 0.000 description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000021014 blueberries Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- 235000008210 xanthophylls Nutrition 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004402 high myopia Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000004243 retinal function Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种提供眼睛营养保护视力的复合配方，按重量百分比，包括：叶黄素酯微囊粉3‑6％，蓝莓提取物3‑7％，紫苏籽油微囊粉15‑25％，玉米黄质微囊粉1‑3％，麦芽糊精25‑35％，植物油12‑20％，乳粉8‑12％、二氧化硅0.5‑1％，食品用香精3‑5％，三氯蔗糖0.1‑0.2‰。此复合配方不仅解决了眼睛所需要补充的营养难题，而且大大的提高了吸收转化率的难题。
Description
技术领域
本发明属于配制营养药品领域，尤其涉及一种提供眼睛营养保护视力的复合配方及其制备方法。
背景技术
目前，在电子设备占据我们大多数人的视觉生活的同时，视力也成为很多人苦恼的事情，无论是用眼过度的学生，还是每天面对电脑超过8小时的上班族，再或是上了岁数的老年人，都或多或少地出现眼睛酸涩、疲劳、疼痛、流泪等不适症状。
出现以上症状大体可分为外源性和内源性两种损伤。外源性包括各种电子设备释放蓝紫光对眼睛的直接伤害、长时间面对电脑得不到休息而引起的视疲劳、风沙雾霾等引起的眼干涩等；内源性包括人到老年身体器官、功能开始退化，人体机能减退，如老年黄斑退化和白内障等；另外，糖尿病、高血压所导致的各种眼疾以及抽烟饮酒对眼睛的直接损伤等。
如此多的不良因素影响着我们的眼睛，看来保护眼睛，势在必行。那么，怎样才能有效预防和缓解呢？很多人做了眼保健操，也补充了维生素，可是效果并不明显。市面上也有以叶黄素为主要原料制成的产品，有片剂及胶囊等剂型，对眼部保护有一定的作用，但是其对光、热稳定性差，耐胃酸性差，容易发生降解，在人体小肠吸收过程中，生物利用率低，吸收转化率仅为60％左右。
发明内容
本发明的目的是为克服上述现有技术的不足，提供一种提供眼睛营养保护视力的复合配方及其制备方法。
为实现上述目的，本发明采用下述技术方案：
一种提供眼睛营养保护视力的复合配方，按重量百分比，包括：叶黄素酯微囊粉3-6％，蓝莓提取物3-7％，紫苏籽油微囊粉15-25％，玉米黄质微囊粉1-3％，麦芽糊精25-35％，植物油12-20％，乳粉8-12％、二氧化硅0.5-1％，食品用香精3-5％，三氯蔗糖0.1-0.2‰。
上述复合配方的制备方法步骤有：
步骤1，将重量轻的物料叶黄素酯微囊粉、蓝莓提取物、玉米黄质微囊粉、二氧化硅、食品用香精、三氯蔗糖按配方比例称量后，经三维混合机混合均匀；
步骤2，将步骤1中混合均匀后的混合物再与分别称重后的紫苏籽油微囊粉、麦芽糊精、植物油、乳粉一起混合均匀；
步骤3，将步骤2中混匀后的混合物置于60-70℃的环境中干燥5小时，并进行灭菌，并在净化车间冷却后进行粉剂灌装。
本发明提供一种提供眼睛营养保护视力的复合配方及其制备方法，包含叶黄素酯，经科研人员研究，发现酯化了的叶黄素，即叶黄素酯对光、热稳定性强，耐胃酸性及耐金属离子性强，不宜消耗降解，在生物利用率方面高于叶黄素1.6倍；叶黄素酯在人体可自然水解为游离态叶黄素，游离态叶黄素进补眼底发挥效能；而且该复合配方中除了叶黄素酯，还配备了玉米黄质、蓝莓提取物、紫苏籽油等物质，其中玉米黄质也是视网膜中黄斑区域的重要组成部分，蓝莓中的花青素可促进视网膜细胞中视紫质的再生成，紫苏籽油中的а-亚麻酸的摄入能明显改善老年人的视网膜功能，减缓神经功能衰退，并能够提高视力。另外，该复合配方产品运用了微囊化技术，微囊制剂肉眼看是粉状，显微镜下观看是一颗颗由特殊的囊材包裹的微小胶囊，该微囊制剂的最大优点是靶向定位分解，有效率可提高90％-200％，此复合配方不仅解决了眼睛所需要补充的营养难题，而且大大的提高了吸收转化率的难题。
具体实施方式
下面结合实施例对本发明进一步说明。
一种提供眼睛营养保护视力的复合配方，按重量百分比，包括：叶黄素酯微囊粉3-6％，蓝莓提取物3-7％，紫苏籽油微囊粉15-25％，玉米黄质微囊粉1-3％，麦芽糊精25-35％，植物油12-20％，乳粉8-12％、二氧化硅0.5-1％，食品用香精3-5％，三氯蔗糖0.1-0.2‰。
叶黄素酯为眼睛的重要的基础营养，2008年被卫生部认定为新资源食品。叶黄素酯在人体内自动水解成的叶黄素是构成人眼视网膜黄斑区的重要成分，大量流行病学证明，叶黄素对视觉有保护作用。
玉米黄质作为眼睛的重要的基础营养，是一种强抗氧化剂，它可以淬灭单线态氧和光敏剂的三重态，清除损害性氧自由基，防止膜脂过氧化，减少脂褐素的形成，进而防止白内障的形成。
紫苏子油是以紫苏为原料的食用油，含α-亚麻酸达56.14-64.82％，对人体具有更显著的保健和医药功效，而α-亚麻酸同样是眼睛的基础营养物质。
蓝莓中的花青素可促进视网膜细胞中视紫质的再生成，可预防重度近视及视网膜剥离，并可增进视力。同时更有加速视紫质再生的能力，而视紫质正是良好视力不可或缺的东西。
上述一种提供眼睛营养保护视力的复合配方的制备方法步骤有：
实施例一
步骤1，将重量轻的物料叶黄素酯微囊粉3％、蓝莓提取物6％、玉米黄质微囊粉1％、二氧化硅1％、食品用香精4％、三氯蔗糖0.1‰按配方比例称量后，经三维混合机混合均匀；
步骤2，将步骤1中混合均匀后的混合物再与分别称重后的紫苏籽油微囊粉25％、麦芽糊精30％、植物油20％、乳粉10％一起混合均匀；
步骤3，将步骤2中混匀后的混合物置于60-70℃的环境中干燥5小时，并进行灭菌，并在净化车间冷却后进行粉剂灌装。
实施例二
步骤1，将重量轻的物料叶黄素酯微囊粉6％、蓝莓提取物7％、玉米黄质微囊粉3％、二氧化硅1％、食品用香精3％、三氯蔗糖0.2‰按配方比例称量后，经三维混合机混合均匀；
步骤2，将步骤1中混合均匀后的混合物再与分别称重后的紫苏籽油微囊粉15％、麦芽糊精35％、植物油18％、乳粉12％一起混合均匀；
步骤3，将步骤2中混匀后的混合物置于60-70℃的环境中干燥5小时，并进行灭菌，并在净化车间冷却后进行粉剂灌装。
实施例三
步骤1，将重量轻的物料叶黄素酯微囊粉5％、蓝莓提取物4％、玉米黄质微囊粉2％、二氧化硅0.5％、食品用香精5％、三氯蔗糖0.1‰按配方比例称量后，经三维混合机混合均匀；
步骤2，将步骤1中混合均匀后的混合物再与分别称重后的紫苏籽油微囊粉24％、麦芽糊精33％、植物油18.5％、乳粉8％一起混合均匀；
步骤3，将步骤2中混匀后的混合物置于60-70℃的环境中干燥5小时，并进行灭菌，并在净化车间冷却后进行粉剂灌装。
上述虽然对本发明的具体实施方式进行了描述，但并非对本发明保护范围的限制，所属领域技术人员应该明白，在本发明的技术方案的基础上，本领域技术人员不需要付出创造性劳动即可做出的各种修改或变形仍在本发明的保护范围以内。
Claims (2)
1.一种提供眼睛营养保护视力的复合配方，其特征在于，按重量百分比，包括：叶黄素酯微囊粉3-6％，蓝莓提取物3-7％，紫苏籽油微囊粉15-25％，玉米黄质微囊粉1-3％，麦芽糊精25-35％，植物油12-20％，乳粉8-12％、二氧化硅0.5-1％，食品用香精3-5％，三氯蔗糖0.1-0.2‰。
2.根据权利要求1所述的提供眼睛营养保护视力的复合配方的制备方法，其特征在于，包括以下步骤：
步骤1，将重量轻的物料叶黄素酯微囊粉、蓝莓提取物、玉米黄质微囊粉、二氧化硅、食品用香精、三氯蔗糖按配方比例称量后，经三维混合机混合均匀；
步骤2，将步骤1中混合均匀后的混合物再与分别称重后的紫苏籽油微囊粉、麦芽糊精、植物油、乳粉一起混合均匀；
步骤3，将步骤2中混匀后的混合物置于60-70℃的环境中干燥5小时，并进行灭菌，并在净化车间冷却后进行粉剂灌装。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610624311.4A CN106138199A (zh) | 2016-07-29 | 2016-07-29 | 一种提供眼睛营养保护视力的复合配方及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610624311.4A CN106138199A (zh) | 2016-07-29 | 2016-07-29 | 一种提供眼睛营养保护视力的复合配方及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106138199A true CN106138199A (zh) | 2016-11-23 |
Family
ID=57328535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610624311.4A Pending CN106138199A (zh) | 2016-07-29 | 2016-07-29 | 一种提供眼睛营养保护视力的复合配方及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106138199A (zh) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107375505A (zh) * | 2017-08-15 | 2017-11-24 | 庞会心 | 一种预防和治疗眼部疾病的组合物及其制备方法与应用 |
| CN107616399A (zh) * | 2017-09-30 | 2018-01-23 | 山东瑞芝生物科技有限公司 | 一种叶黄素酯微囊饮品及其制备方法 |
| CN107897910A (zh) * | 2017-11-20 | 2018-04-13 | 江苏艾兰得营养品有限公司 | 一种保护视力缓解眼部疲劳的制剂及其制备方法 |
| CN108077438A (zh) * | 2017-12-29 | 2018-05-29 | 澳优乳业（中国）有限公司 | 一种护眼调制乳粉及其制备方法 |
| CN108208815A (zh) * | 2018-02-06 | 2018-06-29 | 山东圣海保健品有限公司 | 蓝莓和叶黄素酯双色复合片及其制备方法 |
| CN108294297A (zh) * | 2017-02-24 | 2018-07-20 | 南通励成生物工程有限公司 | 一种叶黄素营养强化剂的制备方法 |
| CN108713760A (zh) * | 2018-05-14 | 2018-10-30 | 青岛欧潽凯药业有限公司 | 一种抗疲劳护眼营养液及其制备方法 |
| CN109123646A (zh) * | 2018-09-30 | 2019-01-04 | 广东亿超生物科技有限公司 | 一种含玉米黄质、叶黄素酯的制品及制做方法 |
| CN113331420A (zh) * | 2021-06-21 | 2021-09-03 | 北京兰厚化妆品有限责任公司 | 一种保护眼睛的组合物、其保健食品及制备方法 |
| CN117224521A (zh) * | 2023-10-17 | 2023-12-15 | 大连医诺生物股份有限公司 | 一种高活性抵御蓝光损伤的组合物及其制备方法 |
| CN117243929A (zh) * | 2023-10-17 | 2023-12-19 | 大连医诺生物股份有限公司 | 一种类胡萝卜素制剂的组合物及其制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030229142A1 (en) * | 2002-06-05 | 2003-12-11 | Kancor Flavours And Extracts Limited | Novel trans-lutein enriched xanthophyll ester concentrate and a process for its preparation |
| CN101675747A (zh) * | 2008-09-19 | 2010-03-24 | 内蒙古伊利实业集团股份有限公司 | 含有叶黄素酯和玉米黄质的液态乳制品及其生产方法 |
| CN101830841A (zh) * | 2010-05-17 | 2010-09-15 | 刘温来 | 叶黄素浸膏制高含量玉米黄质的方法 |
| CN105559066A (zh) * | 2015-12-28 | 2016-05-11 | 青岛自然珍萃生物科技有限公司 | 一种含有叶黄素酯、玉米黄质、蓝莓、枸杞的咀嚼片及其制备方法 |
| CN105795474A (zh) * | 2016-03-30 | 2016-07-27 | 北京元莱健康管理有限公司 | 一种营养视觉细胞、改善调节能力及抵御蓝光损伤的组合物及其制备方法 |
-
2016
- 2016-07-29 CN CN201610624311.4A patent/CN106138199A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030229142A1 (en) * | 2002-06-05 | 2003-12-11 | Kancor Flavours And Extracts Limited | Novel trans-lutein enriched xanthophyll ester concentrate and a process for its preparation |
| CN101675747A (zh) * | 2008-09-19 | 2010-03-24 | 内蒙古伊利实业集团股份有限公司 | 含有叶黄素酯和玉米黄质的液态乳制品及其生产方法 |
| CN101830841A (zh) * | 2010-05-17 | 2010-09-15 | 刘温来 | 叶黄素浸膏制高含量玉米黄质的方法 |
| CN105559066A (zh) * | 2015-12-28 | 2016-05-11 | 青岛自然珍萃生物科技有限公司 | 一种含有叶黄素酯、玉米黄质、蓝莓、枸杞的咀嚼片及其制备方法 |
| CN105795474A (zh) * | 2016-03-30 | 2016-07-27 | 北京元莱健康管理有限公司 | 一种营养视觉细胞、改善调节能力及抵御蓝光损伤的组合物及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 任迪锋主编: "《现代食品加工技术》", 31 August 2015, 中国农业科学技术出版社 * |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108294297A (zh) * | 2017-02-24 | 2018-07-20 | 南通励成生物工程有限公司 | 一种叶黄素营养强化剂的制备方法 |
| CN107375505A (zh) * | 2017-08-15 | 2017-11-24 | 庞会心 | 一种预防和治疗眼部疾病的组合物及其制备方法与应用 |
| CN107616399A (zh) * | 2017-09-30 | 2018-01-23 | 山东瑞芝生物科技有限公司 | 一种叶黄素酯微囊饮品及其制备方法 |
| CN107897910A (zh) * | 2017-11-20 | 2018-04-13 | 江苏艾兰得营养品有限公司 | 一种保护视力缓解眼部疲劳的制剂及其制备方法 |
| CN108077438A (zh) * | 2017-12-29 | 2018-05-29 | 澳优乳业（中国）有限公司 | 一种护眼调制乳粉及其制备方法 |
| CN108208815A (zh) * | 2018-02-06 | 2018-06-29 | 山东圣海保健品有限公司 | 蓝莓和叶黄素酯双色复合片及其制备方法 |
| CN108713760A (zh) * | 2018-05-14 | 2018-10-30 | 青岛欧潽凯药业有限公司 | 一种抗疲劳护眼营养液及其制备方法 |
| CN109123646A (zh) * | 2018-09-30 | 2019-01-04 | 广东亿超生物科技有限公司 | 一种含玉米黄质、叶黄素酯的制品及制做方法 |
| CN113331420A (zh) * | 2021-06-21 | 2021-09-03 | 北京兰厚化妆品有限责任公司 | 一种保护眼睛的组合物、其保健食品及制备方法 |
| CN117224521A (zh) * | 2023-10-17 | 2023-12-15 | 大连医诺生物股份有限公司 | 一种高活性抵御蓝光损伤的组合物及其制备方法 |
| CN117243929A (zh) * | 2023-10-17 | 2023-12-19 | 大连医诺生物股份有限公司 | 一种类胡萝卜素制剂的组合物及其制备方法 |
| CN117243929B (zh) * | 2023-10-17 | 2025-08-19 | 大连医诺生物股份有限公司 | 一种类胡萝卜素制剂的组合物及其制备方法 |
| CN117224521B (zh) * | 2023-10-17 | 2025-09-02 | 大连医诺生物股份有限公司 | 一种高活性抵御蓝光损伤的组合物及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106138199A (zh) | 一种提供眼睛营养保护视力的复合配方及其制备方法 | |
| CN102144780A (zh) | 一种保护视力的叶黄素酯保健品及其制备方法 | |
| CN101904502B (zh) | 复方叶黄素软胶囊及制备方法 | |
| CN108157568A (zh) | 一种缓解视疲劳的组合糖果及其制备方法和用途 | |
| CN104147081A (zh) | 改善视力的蓝莓叶黄素软胶囊及制作方法 | |
| CN107837288A (zh) | 一种缓解视疲劳的复方花青素叶黄素酯软胶囊 | |
| CN108713760A (zh) | 一种抗疲劳护眼营养液及其制备方法 | |
| CN109645201A (zh) | 含有叶黄素和叶黄素酯的组合物、叶黄素压片糖及制备方法和应用 | |
| CN109805400A (zh) | 一种缓解视疲劳的越橘叶黄素保健食品 | |
| CN101283806A (zh) | 一种含天然叶黄素的膳食补充剂及制备工艺 | |
| CN111202243A (zh) | 强化明目营养软胶囊特殊膳食食品及其制备方法 | |
| CN107897910A (zh) | 一种保护视力缓解眼部疲劳的制剂及其制备方法 | |
| CN102960604B (zh) | 一种木糖醇叶黄素固体饮料及制备方法 | |
| CN106617055A (zh) | 一种改善退化性眼疾的护眼保健食品及其制备方法 | |
| CN105520137B (zh) | 一种具有缓解视疲劳和保护视力功能的保健食品 | |
| KR20170142520A (ko) | 반려동물 안과질환 관리 보조영양제와 그 제조방법 | |
| CN108041609A (zh) | 一种具有缓解视疲劳、预防近视的食品组合物及其制备方法 | |
| CN116211939A (zh) | 一种修复视神经增强视力的组合物及应用 | |
| CN107259566A (zh) | 一种稳定高效护眼、提高视力的组合物及制备方法和应用 | |
| CN106692187A (zh) | 一种用于改善明视持久度、保护眼睛健康的组合物 | |
| CN114747704A (zh) | 护眼美容养颜饮料及其制备方法 | |
| CN102178018A (zh) | 保护视力水果咀嚼片配方及其制备方法 | |
| CN106490619A (zh) | 一种缓解视疲劳、预防视力减退的保健食品 | |
| CN110226751A (zh) | 一种具有眼保护功效的组合物 | |
| CN106692259A (zh) | 一种用于改善眩光刺激的组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161123 |